+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
UCB (Union chimique belge) - logo

UCB is a global biopharmaceutical company that focuses on neurology and immunology. The company’s core products are Cimzia, Vimpat, Neupro, Keppra and Briviact, and they are also preparing the launch of a potential medicine to help patients with osteoporosis. It offers products for the treatment of central nervous system disorders, allergy and respiratory diseases, and immune and inflammatory disorders. UCB employs over 7,000 people and is based in Brussels, Belgium.

Research Report on China's Levetiracetam Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Levetiracetam Market, 2021-2025

  • Report
  • September 2021
  • 40 Pages
  • China
From
Rheumatoid Arthritis - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Rheumatoid Arthritis - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Central Nervous System Collaboration and Licensing Deals 2019-2024 - Product Thumbnail Image

Central Nervous System Collaboration and Licensing Deals 2019-2024

  • Report
  • October 2024
  • 500 Pages
  • Global
From
Crohn`s Disease (CD) Therapy - Global Strategic Business Report - Product Thumbnail Image

Crohn`s Disease (CD) Therapy - Global Strategic Business Report

  • Report
  • April 2025
  • 142 Pages
  • Global
From
TNF Inhibitors - Global Strategic Business Report - Product Thumbnail Image

TNF Inhibitors - Global Strategic Business Report

  • Report
  • April 2025
  • 191 Pages
  • Global
From
Autoimmune Disease Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Autoimmune Disease Therapeutics - Global Strategic Business Report

  • Report
  • April 2025
  • 456 Pages
  • Global
From
Parkinson's Disease by Major Markets - Size, Trends and Drug Forecast including Epidemiology, Disease Management, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Pipeline Analysis to 2029 - Product Thumbnail Image

Parkinson's Disease by Major Markets - Size, Trends and Drug Forecast including Epidemiology, Disease Management, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Pipeline Analysis to 2029

  • Drug Pipelines
  • July 2023
  • 139 Pages
  • Global
From
Monoclonal Antibodies Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026) - Product Thumbnail Image

Monoclonal Antibodies Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

  • Report
  • July 2021
  • 120 Pages
  • Global
From
Ankylosing Spondylitis (AS) - Market Insights, Epidemiology, and Market Forecast - 2032 - Product Thumbnail Image

Ankylosing Spondylitis (AS) - Market Insights, Epidemiology, and Market Forecast - 2032

  • Report
  • February 2022
  • 210 Pages
  • Global
From
Krabbe Disease Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Krabbe Disease Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 99 Pages
  • Global
From
Novel Drug Reconstitution Systems Market by Type of Container, Fabrication Material, Physical State of Drug in Syringe and Cartridge, Physical State of Drug in Infusion Bag, Volume of Container, Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2030 - Product Thumbnail Image

Novel Drug Reconstitution Systems Market by Type of Container, Fabrication Material, Physical State of Drug in Syringe and Cartridge, Physical State of Drug in Infusion Bag, Volume of Container, Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2030

  • Report
  • September 2021
  • 325 Pages
  • Global
From
Acute Repetitive Seizures - Global Strategic Business Report - Product Thumbnail Image

Acute Repetitive Seizures - Global Strategic Business Report

  • Report
  • April 2025
  • 92 Pages
  • Global
From
Epilepsy Drugs - Global Strategic Business Report - Product Thumbnail Image

Epilepsy Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 93 Pages
  • Global
From
Parkinson's Disease Treatment - Global Strategic Business Report - Product Thumbnail Image

Parkinson's Disease Treatment - Global Strategic Business Report

  • Report
  • April 2025
  • 93 Pages
  • Global
From
Neurodegenerative Drugs - Global Strategic Business Report - Product Thumbnail Image

Neurodegenerative Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 344 Pages
  • Global
From
Antibody Drugs: Technologies and Global Markets - Product Thumbnail Image

Antibody Drugs: Technologies and Global Markets

  • Report
  • September 2024
  • 156 Pages
  • Global
From
Europe Constrained Peptide Drugs Market: Analysis and Forecast, 2024-2040 - Product Thumbnail Image

Europe Constrained Peptide Drugs Market: Analysis and Forecast, 2024-2040

  • Report
  • January 2024
  • 84 Pages
  • Europe
From
US Orphan Drugs Market, Drugs Sales, Price, Dosage & Clinical Trials Insight 2028 - Product Thumbnail Image

US Orphan Drugs Market, Drugs Sales, Price, Dosage & Clinical Trials Insight 2028

  • Report
  • July 2023
  • 3600 Pages
  • United States
From
Constrained Peptide Drugs Market - A Global and Regional Analysis: Focus on Peptide Type, Product, and Region-Wise Analysis - Analysis and Forecast, 2024-2040 - Product Thumbnail Image

Constrained Peptide Drugs Market - A Global and Regional Analysis: Focus on Peptide Type, Product, and Region-Wise Analysis - Analysis and Forecast, 2024-2040

  • Report
  • May 2023
  • 229 Pages
  • Global
From
Epilepsy Drugs Market Size, Share & Trends Analysis Report by Treatment (First Generation Anti-Epileptics, Second Generation Anti-Epileptics), Distribution Channel, and Region with Growth Forecasts, 2025-2030 - Product Thumbnail Image

Epilepsy Drugs Market Size, Share & Trends Analysis Report by Treatment (First Generation Anti-Epileptics, Second Generation Anti-Epileptics), Distribution Channel, and Region with Growth Forecasts, 2025-2030

  • Report
  • February 2025
  • 90 Pages
  • Global
From
Loading Indicator